Skip to main content
editorial
. 2020 Apr 24;78(1):1–3. doi: 10.1016/j.eururo.2020.04.039

Figure 1.

Figure 1

Adjustments in the use of intravesical instillations of bacillus Calmette-Guérin (BCG) for high-risk non–muscle-invasive bladder cancer (NMIBC) during the COVID-19 pandemic.